Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Mountain Valley MD Holdings Inc MVMDF


Primary Symbol: C.MVMD

Metals & Mining Gold
Mountain Valley MD Holdings Inc. is a Canada-based biotech company, which is focused on advancing solutions to optimize human, animal, and plant health. The Company is focused on implementation, licensing and reselling of key technologies and formulations, such as Quicksome oral formulation and delivery technologies, Quicksol solubility formulation technology, and Agrarius, a novel agricultural... see more

Recent & Breaking News (CSE:MVMD)

CSE Bulletin: Index - CSE 25 Index Quarterly Rebalancing

Newsfile September 17, 2021

Mountain Valley MD Holdings Announces Voluntary Retraction of a Reported Data Set, No Material Change to Business Plan Anticipated

GlobeNewswire September 15, 2021

Mountain Valley MD Holdings Announces Annual Shareholder Meeting

GlobeNewswire September 9, 2021

OTC Markets Group Welcomes Mountain Valley MD Holdings Inc. to OTCQX

PR Newswire August 27, 2021

Mountain Valley MD Holdings to Graduate to OTCQX Best Market, Updates Broader Up-Listing Strategy

GlobeNewswire August 26, 2021

Mountain Valley MD Appoints Chief Medical Officer

GlobeNewswire August 3, 2021

Mountain Valley MD Announces Appointment of Advisors, Stock Option Grant and Provides Uplisting Update

GlobeNewswire July 15, 2021

Mountain Valley MD Announces Results From Cold Chain Storage Evaluation of Novel Quicksome(TM) Technology

GlobeNewswire July 7, 2021

Mountain Valley MD Provides Update on Key Strategic Initiatives: Patent Award, FDA Collaborative Research Agreement, Cold Chain, Dose Sparing, Husbandry, Oncology, TB, Cannabis

GlobeNewswire June 24, 2021

Mountain Valley MD to Host Live, Virtual Town Hall Q&A Session with Company President & CEO, Dennis Hancock

Canada NewsWire May 21, 2021

Mountain Valley MD Receives Successful Results From BSL-4 COVID-19 Clearance Trial on Three Variants Tested With Ivectosol(TM)

GlobeNewswire May 18, 2021

Mountain Valley MD Provides Update on Current Trials

Canada NewsWire May 11, 2021

Mountain Valley MD Proceeding With Pre-Clinical Cancer Trials, Files Related Cancer Patent

Canada NewsWire May 5, 2021

Mountain Valley MD Proceeding With Pre-Clinical Cancer Trials, Files Related Cancer Patent

Canada NewsWire May 3, 2021

Mountain Valley MD Holdings Inc. Proceeding with Application to List on the TSX Venture Exchange

Canada NewsWire April 20, 2021

IIROC Trading Halt - MVMD

Canada NewsWire March 16, 2021

IIROC Trade Resumption - MVMD

Canada NewsWire March 16, 2021

Mountain Valley MD Commencing Trials in Bangladesh, Striking Pharmaceutical Production Agreements

Canada NewsWire March 16, 2021

IIROC Trading Halt - MVMD

Canada NewsWire March 15, 2021

Mountain Valley MD Achieves Solubilization of Selamectin, Files Trademark For Selactosol(TM)

Canada NewsWire March 10, 2021